Increased incidence of endophthalmitis after vitrectomy relative to face mask wearing during COVID-19 pandemic.
Covid-19
Infection
Retina
Journal
The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
03
03
2022
accepted:
22
05
2022
medline:
25
9
2023
pubmed:
22
6
2022
entrez:
21
6
2022
Statut:
ppublish
Résumé
To determine the incidence and causative pathogens of endophthalmitis after vitrectomy during strict face mask wearing in the COVID-19 period. This was a retrospective multicentre study including 31 ophthalmological institutions of the Japanese Retina and Vitreous Society or Japan-Clinical Retina Study group. Patients who had undergone vitrectomy during 2019, the pre-COVID-19 period, and from July 2020 to June 2021, the COVID-mask period, were studied. The results of cataract surgery were used as a control. The total number of vitrectomies and the total number of postoperative endophthalmitis were determined. Then, the differences in the incidence of postoperative endophthalmitis between the pre-COVID-19 period and the COVID-mask period, and the type of pathogens causing the endophthalmitis were studied. The incidence of postvitrectomy endophthalmitis was significantly lower in the pre-COVID-19 period with 16 568 surgeries and 18 endophthalmitis cases (0.11%) than in the COVID-mask period of 14 929 surgeries and 31 endophthalmitis cases (0.21%; p=0.031, OR=1.913, 95% CI 1.078 to 3.394). In the pre-COVID-19 period, 4 of the 18 eyes were culture positive, and all were of the It is necessary for physicians to be aware of the higher incidence of postvitrectomy endophthalmitis during the COVID-mask period, and to treat their patients appropriately.
Sections du résumé
BACKGROUND/AIMS
To determine the incidence and causative pathogens of endophthalmitis after vitrectomy during strict face mask wearing in the COVID-19 period.
METHODS
This was a retrospective multicentre study including 31 ophthalmological institutions of the Japanese Retina and Vitreous Society or Japan-Clinical Retina Study group. Patients who had undergone vitrectomy during 2019, the pre-COVID-19 period, and from July 2020 to June 2021, the COVID-mask period, were studied. The results of cataract surgery were used as a control. The total number of vitrectomies and the total number of postoperative endophthalmitis were determined. Then, the differences in the incidence of postoperative endophthalmitis between the pre-COVID-19 period and the COVID-mask period, and the type of pathogens causing the endophthalmitis were studied.
RESULTS
The incidence of postvitrectomy endophthalmitis was significantly lower in the pre-COVID-19 period with 16 568 surgeries and 18 endophthalmitis cases (0.11%) than in the COVID-mask period of 14 929 surgeries and 31 endophthalmitis cases (0.21%; p=0.031, OR=1.913, 95% CI 1.078 to 3.394). In the pre-COVID-19 period, 4 of the 18 eyes were culture positive, and all were of the
CONCLUSIONS
It is necessary for physicians to be aware of the higher incidence of postvitrectomy endophthalmitis during the COVID-mask period, and to treat their patients appropriately.
Identifiants
pubmed: 35728937
pii: bjophthalmol-2022-321357
doi: 10.1136/bjophthalmol-2022-321357
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1472-1477Investigateurs
Shigehiko Kitano
(S)
Kunihiro Ishikawa
(K)
Yasuhiro Ikeda
(Y)
Naohiro Sugita
(N)
Go Mawatari
(G)
Hiroshi Enaida
(H)
Soichiro Yamamoto
(S)
Yoshiyuki Kobayashi
(Y)
Taiji Sakamoto
(T)
Toshifumi Yamashita
(T)
Hiroto Terasaki
(H)
Ryoh Funatsu
(R)
Hideki Shiihara
(H)
Koh-Hei Sonoda
(KH)
Atsunobu Takeda
(A)
Keijiro Ishikawa
(K)
Shoji Notomi
(S)
Muneo Yamaguchi
(M)
Shunji Nakatake
(S)
Hideki Koizumi
(H)
Yukihide Yamauchi
(Y)
Nobuhiro Terao
(N)
Naoya Imanaga
(N)
Shota Sawaguchi
(S)
Susumu Ishida
(S)
Ryo Ando
(R)
Riki Kijima
(R)
Fumi Gomi
(F)
Takashi Araki
(T)
Norihito Doi
(N)
Takashi Mizushima
(T)
Yuko Fujiwara
(Y)
Shoki Miyake
(S)
Yuka Mizushima
(Y)
Kihoko Kato
(K)
Kiyoshi Suzuma
(K)
Yuki Nakano
(Y)
Rie Osaka
(R)
Akinori Uemura
(A)
Keita Yamakiri
(K)
Shigeo Yoshida
(S)
Nobuhiro Kato
(N)
Kei Furushima
(K)
Mineo Kondo
(M)
Kumiko Kato
(K)
Nahoko Ogata
(N)
Tetsuo Ueda
(T)
Yuutaro Mizusawa
(Y)
Hironobu Jimura
(H)
Masaru Takeuchi
(M)
Takayuki Kanda
(T)
Tomohito Sato
(T)
Shunji Kusaka
(S)
Chiharu Iwahashi
(C)
Sayaka Yamao
(S)
Takatoshi Maeno
(T)
Hidetaka Masahara
(H)
Toshinori Murata
(T)
Takao Hirano
(T)
Masahito Ohji
(M)
Tomoko Sawada
(T)
Yoko Ozawa
(Y)
Norihiro Nagai
(N)
Hitoshi Takagi
(H)
Tatsuya Jujo
(T)
Masahiko Shimura
(M)
Masaki Asakage
(M)
Kanako Yasuda
(K)
Tomohiro Iida
(T)
Ichiro Maruko
(I)
Taiji Hasegawa
(T)
Atsushi Ohnami
(A)
Yukari Kodama
(Y)
Hitoshi Tabuchi
(H)
Daisuke Nagasato
(D)
Kazuaki Kadonosono
(K)
Maiko Maruyama-Inoue
(M)
Shin Tanaka
(S)
Akitaka Tsujikawa
(A)
Kenji Suda
(K)
Tsutomu Yasukawa
(T)
Aki Kato
(A)
Sentaro Kusuhara
(S)
Yasuo Kurimoto
(Y)
Yasuhiko Hirami
(Y)
Masayo Takahashi
(M)
Makoto Inoue
(M)
Akito Hirakata
(A)
Takashi Koto
(T)
Kazunari Hirota
(K)
Tomoka Ishida
(T)
Yoshimasa Ando
(Y)
Masaharu Mizuno
(M)
Aya Takahashi
(A)
Yoshinori Mitamura
(Y)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.